Innovation under regulatory uncertainty: Evidence from medical technology

Innovation under Regulatory Uncertainty: Evidence from Medical Technology.

This paper explores how the regulatory approval process affects innovation incentives in medical technologies. Prior studies have found early mover regulatory advantages for drugs. I find the opposite for medical devices, where pioneer entrants spend 34 percent (7.2 months) longer than follow-on entrants in regulatory approval. Back-of-the- envelope calculations suggest that the cost of a delay...

Strategic Technology Adoption under Technological Uncertainty

strategic technology adoption under technological uncertainty

A Structured Approach to Medical Technology Innovation

The recent decline in the values of technology stocks and the increased focus on a company’s short term earnings has led to increased demand for premium-value products. Innovative product or technology development has been shown to be one of the key drivers behind premium-value technology or products (PVTP) and successful organisations (Packard 1995; Peters & Waterman 1984; Slater 1999; Stross ...

Induced Innovation and Social Inequality: Evidence from Infant Medical Care.

We develop a model of induced innovation that applies to medical research. Our model yields three empirical predictions. First, initial death rates and subsequent research effort should be positively correlated. Second, research effort should be associated with more rapid mortality declines. Third, as a byproduct of targeting the most common conditions in the population as a whole, induced inno...